Drugs / Gengigel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06947161 | Feb → Aug 2025 overdue | pharyngitis | University of Malaya | Recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT07169357 Comparator | Nov 2025 → Feb 2026 overdue | gingival hypertrophy | Beirut Arab University | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gengigel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06947161 ↗ |
| Route | Topical | “topically applied HA gel” PMID 37891549 ↗ Oct 2023 |